Dosing underway in Zymeworks' Phase 1 study of zanidatamab combo in HER+ breasts cancer
July 28 2021 - 8:47AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Zymeworks (NYSE:ZYME)
Historical Stock Chart
From Mar 2024 to Apr 2024
Zymeworks (NYSE:ZYME)
Historical Stock Chart
From Apr 2023 to Apr 2024